| Symbol | DMRA |
|---|---|
| Name | DAMORA THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 221 CRESCENT STREET, WALTHAM, MA 02453 |
| Telephone | (781) 281-9020 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001800315 |
| Description | None |
New Form 3 - Damora Therapeutics, Inc. <b>Filed:</b> 2026-05-08 <b>AccNo:</b> 0001193125-26-214909 <b>Size:</b> 14 KB
Read more(99% Neutral) DAMORA THERAPEUTICS, INC. (DMRA) Announces New Board Appointment
Read moreNew Form ARS - Damora Therapeutics, Inc. <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001193125-26-201367 <b>Size:</b> 2 MB
Read moreDamora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreNew Form DEFA14A - Damora Therapeutics, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001193125-26-191426 <b>Size:</b> 338 KB
Read moreNew Form SCHEDULE 13G/A - Damora Therapeutics, Inc. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001193125-26-174461 <b>Size:</b> 7 KB
Read moreNew Form SCHEDULE 13G/A - Damora Therapeutics, Inc. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001193125-26-174454 <b>Size:</b> 7 KB
Read moreJarrett Jennifer 🟢 acquired 2.0M shares (1 derivative) of Damora Therapeutics, Inc. (DMRA) at $25.50 ($38.2M) Transaction Date: Mar 30, 2026 | Filing ID: 138275
Read moreNew Form 3 - Damora Therapeutics, Inc. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001193125-26-138247 <b>Size:</b> 15 KB
Read moreDamora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more